Covestor’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Buy |
1,782
+798
| +81% | +$25.1K | 0.03% | 848 |
|
|
2025
Q1 | $32K | Sell |
984
-529
| -35% | -$17.2K | 0.02% | 1022 |
|
|
2024
Q4 | $55K | Sell |
1,513
-138
| -8% | -$5.02K | 0.03% | 823 |
|
|
2024
Q3 | $51K | Sell |
1,651
-6
| -0.4% | -$185 | 0.03% | 870 |
|
|
2024
Q2 | $44K | Sell |
1,657
-1,045
| -39% | -$27.7K | 0.03% | 917 |
|
|
2024
Q1 | $92K | Buy |
2,702
+358
| +15% | +$12.2K | 0.06% | 596 |
|
|
2023
Q4 | $68K | Sell |
2,344
-6
| -0.3% | -$174 | 0.05% | 716 |
|
|
2023
Q3 | $65K | Buy |
2,350
+1,257
| +115% | +$34.8K | 0.05% | 648 |
|
|
2023
Q2 | $33K | Buy |
1,093
+230
| +27% | +$6.94K | 0.03% | 952 |
|
|
2023
Q1 | $31K | Buy |
863
+858
| +17,160% | +$30.8K | 0.03% | 878 |
|
|
2022
Q4 | $0 | Sell |
5
-103
| -95% | – | ﹤0.01% | 2604 |
|
|
2022
Q3 | $4K | Buy |
108
+99
| +1,100% | +$3.67K | ﹤0.01% | 1579 |
|
|
2022
Q2 | $0 | Sell |
9
-168
| -95% | – | ﹤0.01% | 2354 |
|
|
2022
Q1 | $6K | Buy |
177
+25
| +16% | +$847 | ﹤0.01% | 1453 |
|
|
2021
Q4 | $4K | Buy |
+152
| New | +$4K | 0.01% | 1421 |
|